PEN-221, identified by its CAS number 1853254-97-3, is a chemical compound that belongs to a class of substances known for their potential therapeutic applications. While specific details about its characteristics may not be widely available due to its relatively recent development or limited research, compounds in this category often exhibit unique structural features that contribute to their biological activity. Typically, such substances may possess functional groups that enhance their solubility, stability, and interaction with biological targets. The molecular weight, melting point, and solubility in various solvents are important physical properties that would be assessed during its characterization. Additionally, PEN-221 may undergo various analytical techniques, such as NMR spectroscopy, mass spectrometry, and chromatography, to confirm its structure and purity. As with many novel compounds, ongoing research is likely focused on elucidating its mechanism of action, pharmacokinetics, and potential therapeutic benefits, particularly in the context of specific diseases or conditions.

PEN-221

1853254-97-3: PEN-221, identified by its CAS number 1853254-97-3, is a chemical compound that belongs to a class of substances known for their potential therapeutic applications. While specific details about its characteristics may not be widely available due to its relatively recent development or limited research, compounds in this category often exhibit unique structural features that contribute to their biological activity. Typically, such substances may possess functional groups that enhance their solubility, stability, and interaction with biological targets. The molecular weight, melting point, and solubility in various solvents are important physical properties that would be assessed during its characterization. Additionally, PEN-221 may undergo various analytical techniques, such as NMR spectroscopy, mass spectrometry, and chromatography, to confirm its structure and purity. As with many novel compounds, ongoing research is likely focused on elucidating its mechanism of action, pharmacokinetics, and potential therapeutic benefits, particularly in the context of specific diseases or conditions.

PEN-221 targets SSTR2; it's a cytotoxic conjugate with DM1 and Tyr3-octreotate, IC50 of 10 nM.

CAS 1853254-97-3

PEN-221

PEN-221

Ref: TM-TP1804